HUGH SHARP: Open Payments
NPI 1740282482 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 50 payments from 8 companies in 2025. Trend: 2023 $603 · 2024 $468 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $293 |
| ABBVIE INC. | 13 | $228 |
| Axsome Therapeutics, Inc. | 5 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Alkermes, Inc. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
Products named: CAPLYTA, VRAYLAR, Auvelity, REXULTI, INGREZZA, ARISTADA, AUSTEDO XR, FANAPT.
Industry payments across AL — which companies pay providers there.
